Converting cytoskeletal forces into biochemical signals
Converting cytoskeletal forces into biochemical signals
批准号:
10655891
负责人:
GREGORY M ALUSHIN
金额:
$33.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-15 至 2027-01-31
关键词:
ActinsBindingBiochemicalBiological ProcessBiophysical ProcessBiophysicsBundlingCell Cycle ArrestCell DeathCell LineCell NucleusCell physiologyCell-Matrix JunctionCellsCellular AssayClustered Regularly Interspaced Short Palindromic RepeatsComplexCoupledCryo-electron tomographyCryoelectron MicroscopyCytoplasmCytoskeletal ModelingCytoskeletonDataDevelopmentDiseaseDissectionEnvironmentEvaluationEventFHL1 geneFilamentFluorescence MicroscopyFunctional disorderGene ExpressionGene Expression RegulationGenerationsGenesHomeostasisIndividualKnock-outLinkLobular NeoplasiaMalignant NeoplasmsMechanicsMediatingMembraneMethodsMicrofilamentsMolecular StructureMotorMuscular DystrophiesMyosin ATPaseNuclearOutcomeOutputPathway interactionsPhysical condensationPolymersProtein EngineeringProteinsReportingResolutionRoleRuptureSignal TransductionSiteStress FibersStructureTechnologyTestingTherapeuticTissuesTranscription Factor AP-1VisualizationWorkZYX genealpha Actininforce feedbackimmune functionin vivoinhibitorinnovationmechanical signalmechanotransductionnanometer resolutionpolymerizationpreventprotein crosslinkreconstitutionreconstructionrecruitrepairedtherapeutic targettranscriptome sequencingtransmission processvasodilator-stimulated phosphoprotein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Cells perceive mechanical cues in their local environments, which must be converted into intracellular
biochemical signals to modulate cellular physiology and control gene expression. There is increasing
appreciation for mechanical signal transduction’s (“mechanotransduction”) critical role in development and its
dysfunction in disease states such as cancer. However, in contrast to canonical signal transduction, cellular force
sensing is poorly understood, hampering efforts to define mechanistically distinct mechanotransduction
pathways, delineate their specific biological functions, and target them therapeutically.
The actin cytoskeleton, a network of dynamic actin filaments, myosin motor proteins, and hundreds of
associated factors, enables cells to mechanically interface with their surroundings. The cytoskeleton is classically
understood to serve as a force generation and transmission apparatus that indirectly facilitates mechano-
transduction through its physical linkages to membrane-anchored sites which mediate force signal conversion
(e.g. cell-cell and cell-matrix adhesions). However, we and others have recently reported direct binding of soluble
cytosolic proteins containing tandem arrays of LIM (LIN-11, Isl-1 & Mec-3) domains to tensed actin filaments,
suggesting that the cytoskeleton itself may have the capacity to transduce forces into biochemical signals. Here
I propose to test the hypothesis that force-activated actin binding by distinct LIM proteins is upstream of
functionally discrete downstream mechanotransduction pathways. Through cellular assays and biophysical
reconstitution, we will investigate how the representative force-activated actin binding LIM proteins zyxin (Aim 1)
and FHL1/2 (Four-and-a-Half LIM domains 1/2, Aim 2) mediate distinct downstream functions in cytoplasmic
cytoskeletal damage repair and nuclear gene expression regulation, respectively. We will then innovatively
interface these approaches with cryo-electron microscopy (cryo-EM) to visualize force-activated actin binding by
LIM proteins in structural detail (Aim 3). Our studies will establish how a conserved mechanism of force
transduction through LIM domains is linked to distinct downstream signaling outcomes, which is likely to reveal
general principles underlying the modular organization of cytoskeletal mechanical signaling networks. In the
longer term, this work will enable precision dissection of context-specific biological functions of LIM proteins in
vivo, facilitating rigorous evaluation of their potential as therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Mechanisms of Cytoskeletal Force-Sensing
-
批准号:10178249
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2021
-
负责人:GREGORY M ALUSHIN
-
依托单位:
Structural Mechanisms of Cytoskeletal Force-Sensing
-
批准号:10382368
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2021
-
负责人:GREGORY M ALUSHIN
-
依托单位:
Structural Mechanisms of Cytoskeletal Force-Sensing
-
批准号:10579395
-
项目类别:
-
资助金额:$14.63万
-
财政年份:2021
-
负责人:GREGORY M ALUSHIN
-
依托单位:
Structural Mechanisms of Cytoskeletal Force-Sensing
-
批准号:10584619
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2021
-
负责人:GREGORY M ALUSHIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: